CarbGeM Presents at Indonesia’s Leading Clinical Microbiology Conference

カーブジェン株式会社

2025-09-10 00:00

“PAMKI Annual Conference 2025”
CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”) participated in the “PAMKI Annual Conference 2025”, held from August 21 (Thu) to 23 (Sat), 2025, in Semarang, Indonesia, and delivered a 25-minute presentation in a sponsored symposium session.

________________________________________

About PAMKI Annual Conference 2025

The PAMKI Annual Conference is organized by the Indonesian Society of Clinical Microbiologists (PAMKI), which brings together clinical microbiologists from across Indonesia, and is recognized as one of the most prestigious academic conferences in the country.
The conference attracts a wide range of participants, including clinical microbiologists, infectious disease specialists, researchers, and government officials. Notably, representatives from the Indonesian Ministry of Health also attended, making the conference a forum where discussions directly influence infection control measures and healthcare policy.
• Organizer: Indonesian Society of Clinical Microbiologists (PAMKI)
• Partner institutions: Diponegoro University, Dr. Kariadi Hospital, Ministry of Health (Kemenkes)

________________________________________

About CarbGeM’s Presentation

CarbGeM delivered a lecture on the potential applications of AI in the field of clinical microbiology.
The presentation highlighted how CarbGeM’s technologies and products, including BiTTE® and CarbConnect®, can contribute to addressing antimicrobial resistance (AMR) and other healthcare challenges in Indonesia.
The presentation was met with strong interest in AI-driven clinical microbiology support, marking an important step toward strengthening collaborations with local partners and advancing healthcare digital transformation (DX) in Indonesia.

________________________________________

About CarbGeM Inc.

CarbGeM Inc. integrates cutting-edge AI and biotechnology to develop and provide DX and AI solutions primarily for the medical and life sciences fields. Through products such as AI-based research software, image analysis platforms, and automated testing devices, the company aims to enhance productivity in clinical and research settings and to help bridge the global gap in access to healthcare.
Official Website: (リンク »)
本プレスリリースは発表元企業よりご投稿いただいた情報を掲載しております。
お問い合わせにつきましては発表元企業までお願いいたします。

【企業の皆様へ】企業情報を掲載・登録するには?

御社の企業情報・プレスリリース・イベント情報・製品情報などを登録するには、企業情報センターサービスへのお申し込みをいただく必要がございます。詳しくは以下のページをご覧ください。

NEWSLETTERS

エンタープライズコンピューティングの最前線を配信

ZDNET Japanは、CIOとITマネージャーを対象に、ビジネス課題の解決とITを活用した新たな価値創造を支援します。
ITビジネス全般については、CNET Japanをご覧ください。

このサイトでは、利用状況の把握や広告配信などのために、Cookieなどを使用してアクセスデータを取得・利用しています。 これ以降ページを遷移した場合、Cookieなどの設定や使用に同意したことになります。
Cookieなどの設定や使用の詳細、オプトアウトについては詳細をご覧ください。
[ 閉じる ]